Research Square · Sep 21, 2026
Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner
By Kane A, Chellappa K, Schultz M et al.
Nicotinamide adenine dinucleotide (NAD+) is essential for many enzymatic reactions. During aging, levels of NAD+ decrease by up to 50%, the repletion of which provides a range of health benefits in both mice and humans. It remains unknown, however, whether the NAD+ precursor nicotinamide mononucleotide (NMN) extends lifespan in mammals. Here, we investigate the effect of long-term NMN on the healthspan and lifespan of male and female mice. In both sexes, NMN reduced frailty, an effect that was associated with increased abundance of Anaerotruncus colihominis, a butyrate-producing gut bacterium. In females, but not males, NMN increased median lifespan by 8.5%, and upregulated mitochondrial function markers in metabolic tissues. In males, but not females, NMN increased physical activity and boosted metabolic health, whilst also upregulating inflammatory pathways, likely as a result of sex-specific increased expression of NAD+ consumers including CD38. These results highlight the potential of NAD+ boosters for treating age-related conditions.
doi.org/10.21203/rs.3.rs-10913337/v1Open accessInterventions